BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31687171)

  • 21. Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial.
    Andersen E; Juhl CR; Kjøller ET; Lundgren JR; Janus C; Dehestani Y; Saupstad M; Ingerslev LR; Duun OM; Jensen SBK; Holst JJ; Stallknecht BM; Madsbad S; Torekov SS; Barrès R
    Hum Reprod; 2022 Jun; 37(7):1414-1422. PubMed ID: 35580859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.
    Shibuya K; Ali KF; Ji X; Milinoivh A; Bauman J; Kattan MW; Pantalone KM; Burguera B
    Endocr Pract; 2019 Oct; 25(10):1022-1028. PubMed ID: 31241358
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study.
    Boger BS; Queiroz NL; Noriega PEP; Canuto MC; Stumpf MAM; Cercato C; Mancini MC; de Melo ME
    Obes Surg; 2023 Sep; 33(9):2941-2944. PubMed ID: 37466830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body weight management in overweight and obese breast cancer survivors.
    Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM).
    Kim DJ; Kang JS; Ahn B; Kim KS; Park KH; Choi KS; Surh YJ; Kim ND
    Cancer Lett; 2001 May; 166(2):125-33. PubMed ID: 11311484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise duration and intensity in a weight-loss program.
    Chambliss HO
    Clin J Sport Med; 2005 Mar; 15(2):113-5. PubMed ID: 15782062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.
    Kahaly GJ; Douglas RS; Holt RJ; Sile S; Smith TJ
    Lancet Diabetes Endocrinol; 2021 Jun; 9(6):360-372. PubMed ID: 33865501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals.
    Hemo B; Endevelt R; Porath A; Stampfer MJ; Shai I
    Diabetes Res Clin Pract; 2011 Nov; 94(2):269-75. PubMed ID: 21907442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction).
    Little P; Stuart B; Hobbs FR; Kelly J; Smith ER; Bradbury KJ; Hughes S; Smith PW; Moore MV; Lean ME; Margetts BM; Byrne CD; Griffin S; Davoudianfar M; Hooper J; Yao G; Zhu S; Raftery J; Yardley L
    Health Technol Assess; 2017 Jan; 21(4):1-62. PubMed ID: 28122658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.
    Garvey WT; Cheng M; Ramasamy A; Smolarz BG; Park S; Kumar N; Kim N; DerSarkissian M; Bhak RH; Duh MS; Wu M; Hansen S; Young-Xu Y
    Popul Health Manag; 2023 Feb; 26(1):72-82. PubMed ID: 36735596
    [No Abstract]   [Full Text] [Related]  

  • 33. Acceptability and feasibility of a planned preconception weight loss intervention in women with long-acting reversible contraception: the Plan-it mixed-methods study.
    Channon S; Coulman E; Cannings-John R; Henley J; Lau M; Lugg-Widger F; Strange H; Davies F; Sanders J; Scherf C; Couzens Z; Morantz L
    Health Technol Assess; 2023 Jan; 27(1):1-224. PubMed ID: 36688498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial.
    Davis LM; Coleman C; Kiel J; Rampolla J; Hutchisen T; Ford L; Andersen WS; Hanlon-Mitola A
    Nutr J; 2010 Mar; 9():11. PubMed ID: 20222968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Super-Users at an Acupuncture and Oriental Medicine Teaching Clinic: Demographics and Unique Clinical Characteristics.
    Cooper F; Marx BL; Lee TL; Espesete D
    J Altern Complement Med; 2017 Mar; 23(3):222-226. PubMed ID: 28170280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Martín-Merino E; Petersen I; Hawley S; Álvarez-Gutierrez A; Khalid S; Llorente-Garcia A; Delmestri A; Javaid MK; Van Staa TP; Judge A; Cooper C; Prieto-Alhambra D
    Osteoporos Int; 2018 Feb; 29(2):467-478. PubMed ID: 29199359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity.
    Shibuya K; Ji X; Pfoh ER; Milinovich A; Weng W; Bauman J; Ganguly R; Misra-Hebert AD; Hobbs TM; Kattan MW; Pantalone KM; Ramasamy A; Burguera B
    Obes Sci Pract; 2020 Jun; 6(3):247-254. PubMed ID: 32523713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grommets (ventilation tubes) for recurrent acute otitis media in children.
    Venekamp RP; Mick P; Schilder AG; Nunez DA
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012017. PubMed ID: 29741289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
    Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.